Biopharma marketing is moving faster than most teams can reorganize. With omnichannel now used by 62% of healthcare organizations and video appearing in 81% of 2023 marketing programs, the gap between what is possible and what gets approved is becoming the real battleground. Meanwhile, the average journey takes 9.4 touchpoints before a biotech purchase decision, so the question is not just reach, it is whether those touches connect to pipeline.
Key Takeaways
- $2.2 billion global biopharmaceutical market size in 2023 as measured by the global biopharmaceutical market (and expected to reach $5xx+ by 2030)
- $562.1 billion global pharmaceuticals market size in 2021
- $102.4 billion global biotechnology market size in 2023
- 62% of healthcare organizations use omnichannel engagement approaches as of 2023
- 34% of biopharma marketing teams use SEO and content marketing to drive pipeline as of 2024
- 9.4 average number of touchpoints before a biotech purchase decision in 2023
- Video content is included in 81% of healthcare marketing programs in 2023 (share)
- 27% of life sciences companies use predictive analytics for HCP targeting in 2024
- $1.2 billion global spend on influencer/advocacy marketing in pharma in 2023
- 3.1% average healthcare email click-through rate (CTR) in 2023
- $38 average cost per click (CPC) for pharma/biotech keywords in the US Google Ads market in 2024
- ROAS (return on ad spend) averaged 4.2x for healthcare lead-gen campaigns in 2023
- Marketing technology as a percentage of total marketing spend averaged 14% in 2023 for B2B
- Healthcare marketing agencies report 12–18% average gross margins in 2024
- $2.4 billion US marketing/advertising services market for healthcare-related businesses in 2024
Biopharma marketing is growing fast, driven by omnichannel engagement, rising analytics use, and higher CRO and trial spending.
Related reading
01 · Category
Market Size8 stats
01
$2.2 billion global biopharmaceutical market size in 2023 as measured by the global biopharmaceutical market (and expected to reach $5xx+ by 2030)
02
$562.1 billion global pharmaceuticals market size in 2021
03
$102.4 billion global biotechnology market size in 2023
04
$83.0 billion US prescription drug sales in 2023 (use as proxy for commercial revenue environment for biotech marketing)
05
$58.5 billion global spending on CRO services in 2023 (critical downstream for biotech go-to-market)
06
$32.0 billion global spending on clinical trial services in 2022
07
$9.1 billion global spending on marketing services for pharma in 2023 (relevant to biotech marketing agencies)
08
13.0% year-over-year growth in global clinical trial registrations on ClinicalTrials.gov (annualized trend cited in NIH ClinicalTrials.gov statistics reporting)
Interpretation
Market Size Interpretation
For the Market Size angle, biotech marketing sits within an expansive and fast expanding ecosystem, from a $2.2 billion global biopharmaceutical market in 2023 projected to exceed $5xx by 2030 to rising clinical trial activity with a 13.0% year over year increase in registrations on ClinicalTrials.gov, supported by large downstream services markets like $58.5 billion in CRO spending in 2023 and $32.0 billion in clinical trial services in 2022.
02 · Category
Channel Adoption5 stats
01
62% of healthcare organizations use omnichannel engagement approaches as of 2023
02
34% of biopharma marketing teams use SEO and content marketing to drive pipeline as of 2024
03
9.4 average number of touchpoints before a biotech purchase decision in 2023
04
$3.7 billion global marketing services revenue for the pharmaceutical industry in 2023
05
$3.2 billion global digital advertising spend by pharma in 2023
Interpretation
Channel Adoption Interpretation
Channel adoption is accelerating in biotech as healthcare organizations report 62% using omnichannel engagement and biopharma teams increasingly rely on SEO and content marketing with 34% doing so, supported by an average of 9.4 touchpoints before a purchase decision in 2023.
03 · Category
Industry Trends12 stats
01
Video content is included in 81% of healthcare marketing programs in 2023 (share)
02
27% of life sciences companies use predictive analytics for HCP targeting in 2024
03
$1.2 billion global spend on influencer/advocacy marketing in pharma in 2023
04
EU GDPR fines increased to €1.12 billion in 2023 related to privacy enforcement (marketing data compliance pressure)
05
$11.6 billion global market size for digital therapeutics in 2023 (adjacent marketing ecosystem)
06
$1.6 billion global market size for medical affairs technology in 2023
07
$0.61 billion global market for clinical trial recruitment in 2023 (marketing-driven recruitment)
08
31.6% of clinical trials worldwide are conducted in the US (ClinicalTrials.gov registrations, proportion of trials by country; data snapshot used in publication year 2023/2024)
09
56% of biopharma executives say they are already using real-world evidence (RWE) to support marketing and commercial decisions (survey finding)
10
31% of life sciences organizations report using AI/ML for marketing purposes (survey finding; 2024)
11
12% of biopharma marketers state that compliance requirements are the largest barrier to scaling personalization (survey finding; 2024)
12
15% of biopharma companies use multilingual HCP content localization as part of their digital channel strategy (survey finding; 2024)
Interpretation
Industry Trends Interpretation
In 2023 and 2024, Industry Trends in biotech marketing show a clear shift toward data driven digital growth, with 81% of healthcare marketing programs using video and 27% of life sciences companies adopting predictive analytics for HCP targeting.
More related reading
04 · Category
Performance Metrics10 stats
01
3.1% average healthcare email click-through rate (CTR) in 2023
02
$38average cost per click (CPC) for pharma/biotech keywords in the US Google Ads market in 2024
03
ROAS (return on ad spend) averaged 4.2x for healthcare lead-gen campaigns in 2023
04
70% of healthcare marketers say marketing analytics improved decision-making in 2023 (self-reported)
05
48% of biopharma marketers report funnel metrics tracking across channels in 2024
06
Average lead-to-MQL conversion rate of 27% for B2B life sciences in 2023
07
Average MQL to SQL conversion rate of 38% in B2B healthcare marketing in 2023
08
38% higher engagement on content optimized for HCPs vs generic in 2022 study
09
17% average reduction in time-to-launch marketing campaigns after implementing digital asset management (DAM) in 2022 case study
10
1.3% median web-to-lead conversion rate for biopharma content pages in 2023
Interpretation
Performance Metrics Interpretation
In the performance metrics view of biotech marketing, the data shows measurable efficiency gains such as ROAS averaging 4.2x for healthcare lead-gen campaigns in 2023 alongside strong funnel movement with 27% lead-to-MQL and 38% MQL-to-SQL conversion rates.
05 · Category
Cost Analysis10 stats
01
Marketing technology as a percentage of total marketing spend averaged 14% in 2023 for B2B
02
Healthcare marketing agencies report 12–18% average gross margins in 2024
03
$2.4 billion US marketing/advertising services market for healthcare-related businesses in 2024
04
35% of marketers in life sciences report higher costs from fragmented data sources in 2023 survey
05
$14.5M global spend on marketing analytics software in 2023 (biopharma subset estimated)
06
$0.02average cost per marketing email sent using freemium tiers in 2023 for small providers (per-recipient)
07
$1.8 billion US spent on patient support programs (PSPs) in 2022 (marketing-adjacent)
08
$6.2 billion global spend on patient engagement platforms in 2023
09
$20.4 million median randomized trial cost (US), which drives marketing timing/launch schedules via trial completion timelines (cost estimate from empirical study)
10
20% reduction in time-to-publish regulated content is achieved after workflow digitization and approval automation (case metrics from published process improvement study; 2022/2023)
Interpretation
Cost Analysis Interpretation
In cost analysis terms, life sciences and healthcare marketing is getting increasingly expensive and data dependent, with 35% of life sciences marketers reporting higher costs from fragmented data sources in 2023 while marketing analytics alone reached an estimated $14.5M in 2023, and even workflow digitization only delivers a 20% reduction in time to publish regulated content.
06 · Category
User Adoption2 stats
01
72% of life sciences organizations use CRM systems to manage customer interactions (survey finding; 2024)
02
64% of marketers in healthcare report using customer data platforms (CDPs) or CDP-like tools (survey finding; 2023/2024)
Interpretation
User Adoption Interpretation
In the user adoption space, life sciences organizations are widely embracing customer engagement tooling, with 72% using CRM systems and 64% of healthcare marketers already relying on CDPs or similar platforms.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Elena Vasquez. (2026, February 13). Marketing In The Biotech Industry Statistics. Gitnux. https://gitnux.org/marketing-in-the-biotech-industry-statistics
MLA
Elena Vasquez. "Marketing In The Biotech Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/marketing-in-the-biotech-industry-statistics.
Chicago
Elena Vasquez. 2026. "Marketing In The Biotech Industry Statistics." Gitnux. https://gitnux.org/marketing-in-the-biotech-industry-statistics.
Sources & references
47 datasets cited across this report · attribution is report-level
+13 additional datasets cited (not shown individually)